On September 3, 2020 Rain Therapeutics Inc., a privately-held, clinical stage biotechnology company focused on targeted therapies for patients with cancer, reported that Avanish Vellanki, chairman and chief executive officer of Rain, will present a corporate overview at Citi’s 15th Annual BioPharma Virtual Conference being held September 8-10, 2020 (Press release, Rain Therapeutics, SEP 3, 2020, View Source [SID1234564399]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s Annual BioPharma Conference
Date: Tuesday, September 8
Time: 10:05 a.m. EDT